These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28404684)

  • 41. Development of selective medium for IMP-type carbapenemase-producing Enterobacteriaceae in stool specimens.
    Yamamoto N; Kawahara R; Akeda Y; Shanmugakani RK; Yoshida H; Hagiya H; Hara N; Nishi I; Yukawa S; Asada R; Sasaki Y; Maeda K; Sakamoto N; Hamada S; Tomono K
    BMC Infect Dis; 2017 Mar; 17(1):229. PubMed ID: 28340557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates.
    Smiljanic M; Kaase M; Ahmad-Nejad P; Ghebremedhin B
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):48. PubMed ID: 28693493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The threat of the carbapenemase-producing enterobacteriaceae in Spain: positioning report of the SEIMC study groups, GEIH and GEMARA].
    Oteo J; Calbo E; Rodríguez-Baño J; Oliver A; Hornero A; Ruiz-Garbajosa P; Horcajada JP; Del Pozo JL; Riera M; Sierra R; Bou G; Salavert M
    Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):666-70. PubMed ID: 24767691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
    Bou G; Vila J; Seral C; Castillo FJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital.
    Ben Helal R; Dziri R; Chedly M; Klibi N; Barguellil F; El Asli MS; Ben Moussa M
    Microb Drug Resist; 2018 Nov; 24(9):1361-1367. PubMed ID: 29596032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
    Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
    J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.
    Humphries RM; McKinnell JA
    J Clin Microbiol; 2015 Dec; 53(12):3712-4. PubMed ID: 26468504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbapenemase-producing Enterobacteriaceae: a 2-year surveillance in a hospital in Iaşi, Romania.
    Braun SD; Dorneanu OS; Vremeră T; Reißig A; Monecke S; Ehricht R
    Future Microbiol; 2016; 11(3):391-401. PubMed ID: 26974389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
    Sidjabat HE; Townell N; Nimmo GR; George NM; Robson J; Vohra R; Davis L; Heney C; Paterson DL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4059-66. PubMed ID: 25918153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road?
    van Duin D; Doi Y
    J Clin Microbiol; 2015 Oct; 53(10):3116-7. PubMed ID: 26202122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.
    French CE; Coope C; Conway L; Higgins JP; McCulloch J; Okoli G; Patel BC; Oliver I
    J Hosp Infect; 2017 Jan; 95(1):3-45. PubMed ID: 27890334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Validation of a Lateral Flow Immunoassay for Rapid Detection of NDM-Producing Enterobacteriaceae.
    Boutal H; Naas T; Devilliers K; Oueslati S; Dortet L; Bernabeu S; Simon S; Volland H
    J Clin Microbiol; 2017 Jul; 55(7):2018-2029. PubMed ID: 28404680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
    Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.
    Palacios-Baena ZR; Oteo J; Conejo C; Larrosa MN; Bou G; Fernández-Martínez M; González-López JJ; Pintado V; Martínez-Martínez L; Merino M; Pomar V; Mora-Rillo M; Rivera MA; Oliver A; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Ortega A; Morales I; Pascual Á; Campos J; Rodríguez-Baño J;
    J Infect; 2016 Feb; 72(2):152-60. PubMed ID: 26546855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.
    Ludden C; Cormican M; Vellinga A; Johnson JR; Austin B; Morris D
    BMC Infect Dis; 2015 Apr; 15():168. PubMed ID: 25887288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates.
    Ansari M; Munir T; Saad N
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):274-278. PubMed ID: 29615166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
    Salgado P; Gilsanz F; Maseda E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The limits of serial surveillance cultures in predicting clearance of colonization with carbapenemase-producing Enterobacteriaceae.
    Lewis JD; Enfield KB; Mathers AJ; Giannetta ET; Sifri CD
    Infect Control Hosp Epidemiol; 2015 Jul; 36(7):835-7. PubMed ID: 25777261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.